All In MedTech

FDA Clearance Tracker · P150037-S007

CyPass System 241-S

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 29, 2018 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 29, 2018

Approved

Time to decision

306 days

Received Jul 27, 2017. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P150037-S007
Device name
CyPass System 241-S
Applicant location
Fort Worth, TX
Received
Jul 27, 2017
Decided
May 29, 2018
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P150037

Device type

Device class
Class III
Specialty
Ophthalmology

Every decision under product code OGO

FDA's approval statement

As written in FDA's record.

Approval for a manufacturing site located at Alcon Research, Ltd, 714 Columbia Avenue, Sinking Spring, Pennsylvania.

Source documents

Other decisions for Alcon Research, Ltd.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.